EMA Authorised: Tauvid (Flortaucipir (18F)) — Eli Lilly Nederland B.V.

View source ↗

Summary

The EMA authorized Tauvid, a radiopharmaceutical PET imaging agent (flortaucipir F18) developed by Eli Lilly Nederland B.V. The product is intended for imaging …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease
• Dementia

Drugs mentioned

• Tauvid (Flortaucipir (18F))

Snippet

Status: Authorised. Therapeutic area: Radionuclide Imaging. MAH: Eli Lilly Nederland B.V.. Decision date: 16/01/2026